Pharmaceutical - Markets & Marketing

Filter

Current filters:

Markets & Marketing

Popular Filters

1 to 25 of 1113 results

Acute coronary syndrome treatment market to more than triple by 2023

Acute coronary syndrome treatment market to more than triple by 2023

30-07-2014

The launch of several drugs with “extraordinary blockbuster potential” will cause the acute coronary…

Acute coronary syndromealirocumabAmgenBayerCardio-vascularEuropeevolocumabJapanMarkets & MarketingMerck & CoPfizerPharmaceuticalSanofiUSAXareltoZontivity

Russia tightens responsibility for sale and production of counterfeit drugs

Russia tightens responsibility for sale and production of counterfeit drugs

30-07-2014

The Russian government has significantly tightened responsibility for the sale and production of counterfeit…

Counterfeit consumer goodsCounterfeit medicationsMarkets & MarketingPharmaceuticalProductionRegulationRussiaRussian government

Global insulin market set to reach $32.24 billion in 2019

Global insulin market set to reach $32.24 billion in 2019

28-07-2014

The global insulin market was valued at $19.99 billion in 2012 and is expected to expand at a compound…

AfrezzaChinaDiabetesEli LillyGlobalInsulinLY2605541MannKindMarkets & MarketingMerck & CoMK-1293NN1218Novo NordiskPharmaceutical

Pharmaceuticals, a strategic sector for the UK government

Pharmaceuticals, a strategic sector for the UK government

28-07-2014

Britain’s pharmaceuticals sector, which includes AstraZeneca and GlaxoSmithKline, two drugmakers among…

AstraZenecaEconomy of the United KingdomFinancialGlaxoSmithKlineMarkets & MarketingPharmaceuticalResearchUK

Brazil and Mexico physicians’ preferences on anticoagulants

25-07-2014

Novel oral anticoagulants (NOACs) such as Bayer’s Xarelto (rivaroxaban), Boehringer Ingelheim’s Pradaxa…

BayerBoehringer IngelheimBrazilBristol-Myers SquibbCardio-vascularEliquisMarkets & MarketingMexicoPfizerPharmaceuticalPradaxaPricingXarelto

Expert View: Has UK pharma lost its Euro-vision?

Expert View: Has UK pharma lost its Euro-vision?

23-07-2014

Former AstraZeneca serialization expert, Christoph Krähenbühl, demystifies the arguments around compliance…

EuropeEuropean UnionMarkets & MarketingMedicines verification infrastructurePharmaceuticalResearchUK

Private health care market in Central Europe looks to gather momentum by 2018

Private health care market in Central Europe looks to gather momentum by 2018

21-07-2014

New data from Poland-based research company PRM is forecasting a revival of the private health care market…

Czech RepublicEuropeHungaryMarkets & MarketingPharmaceuticalPolandPrivate healthcare

Fast growth forecast for dengue vaccine market

Fast growth forecast for dengue vaccine market

18-07-2014

Among the five major pharmaceutical markets (5MM: Brazil, India, Mexico, Singapore and Thailand), Brazil…

Asia-PacificBrazilMarkets & MarketingMexicoPharmaceuticalResearchTropical diseases

FedEx Corp indicted for illegally distributing prescription drugs in USA

FedEx Corp indicted for illegally distributing prescription drugs in USA

18-07-2014

The US Attorney for the Northern District of California yesterday charged the FedEx Corporation with…

LegalMarkets & MarketingPharmaceuticalPharmaceutical sciencesUS AttorneyUSA

Attractions and challenges of Poland’s pharmaceutical market

Attractions and challenges of Poland’s pharmaceutical market

17-07-2014

Not only is Poland the largest pharmaceutical market in the Central & Eastern Europe region and the sixth…

HealthcareMarkets & MarketingPharmaceuticalPolandPricing

Drug-treated hepatitis C population to more than double by 2016

Drug-treated hepatitis C population to more than double by 2016

16-07-2014

The hepatitis C virus population is already large, with 2 million diagnosed, chronically infected cases…

Anti-viralsCytokinesDaklinzaDecision Resources GroupEuropeHepatitis CInterferonJapanMarkets & MarketingPharmaceuticalUSA

Lundbeck and Otsuka file for US approval of brexpiprazole

Lundbeck and Otsuka file for US approval of brexpiprazole

14-07-2014

Danish CNS drug specialist Lundbeck and Japanese drugmaker Otsuka have submitted a New Drug Application…

brexpiprazoleLundbeckMarkets & MarketingNeurologicalOtsukaPharmaceuticalPiperidinesRegulationUSA

US nephrologists view hyperphosphatemia treatment

US nephrologists view hyperphosphatemia treatment

11-07-2014

Surveyed nephrologists report awareness of the US Food and Drug Administration's approval of Vifor Fresenius…

AmgenFreseniusGlaxoSmithKlineLa Jolla PharmaceuticalMarkets & MarketingNephrology and HepatologyOPKO HealthPharmaceuticalRayaldeeSensiparUSAvelcalcetideVelphoroVenoferVifor Pharma

Drug sales up in Brazil while generics take greater market share

09-07-2014

Sales of medicines in Brazil have increased 13% compared to last year, writes Juliane Carvalho of Brazil…

BrazilMarkets & MarketingPharmaceutical

Fidia completes establishment of operations in North America

Fidia completes establishment of operations in North America

08-07-2014

Fidia Pharma USA, a wholly-owned subsidiary of privately-held Italian drugmaker Fidia Farmaceutici, says…

Anti-Arthritics/RheumaticsFidia FarmaceuticiManagementMarkets & MarketingPharmaceuticalUSA

Glowing prospects for Novo Nordisk's insulin degludec/liraglutide for type 2 diabetes

Glowing prospects for Novo Nordisk's insulin degludec/liraglutide for type 2 diabetes

07-07-2014

Danish diabetes care giant Novo Nordisk's fixed-dose combination therapy insulin degludec/liraglutide…

DiabetesEuropeIDegLiraMarkets & MarketingNovo NordiskPharmaceuticalUSAXultophy

Opportunities ripe for Pharma in Ghana and Nigeria

03-07-2014

Strong business opportunities exist for big pharmaceutical and generic pharmaceutical companies in Ghana…

HealthcareMarkets & MarketingPharmaceutical

New entrants in chronic lymphocytic leukemia will raise market value to $3.3 billion by 2018

New entrants in chronic lymphocytic leukemia will raise market value to $3.3 billion by 2018

02-07-2014

The introduction of several new drugs will accelerate growth in the chronic lymphocytic leukemia treatment…

EuropeidelalisibImbruvicaMarkets & MarketingOncologyPharmaceuticalUSA

GSK comments on media coverage of China problems

GSK comments on media coverage of China problems

30-06-2014

UK pharma giant GlaxoSmithKline, already the subject of allegations and investigations of wrongful marketing…

ChinaGlaxoSmithKlineManagementMarkets & MarketingPharmaceutical

1 to 25 of 1113 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top